Drawing for ALMYST

USPTO serial 78465604

ALMYST

Reviewed by CopyMark Law Group

Reg. 3023393Status 710
Filing date
Status date
Registration date
Dec 6, 2005
Examiner
DALIER, JOHN DAVID
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ALMYST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Diane K. Fry

Diane K. Fry GlaxoSmithKlineLGTM, C.3157.3DFive Moore DriveResearch Triangle Park, NC 27709

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, musculoskeletal, cardiopulmonary, genitourinary, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations.SECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 12, 2012C8..CANCELLED SEC. 8 (6-YR)—
May 12, 2010TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 6, 2009ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 6, 2009REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 6, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 13, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 24, 2005NPUBNOTICE OF PUBLICATION—
Aug 3, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 29, 2005ALIEASSIGNED TO LIE—
Jul 22, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 22, 2005DOCKASSIGNED TO EXAMINER—
Jul 22, 2005DOCKASSIGNED TO EXAMINER—
Jul 22, 2005TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 13, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 13, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 17, 2005DOCKASSIGNED TO EXAMINER—
Jan 24, 2005GNSLLETTER OF SUSPENSION E-MAILED—
Jan 24, 2005CNSLSUSPENSION LETTER WRITTEN—
Jan 24, 2005DOCKASSIGNED TO EXAMINER—
Aug 20, 2004NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance